Annual Total Debt
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 26, 2025, MRKR annual total debt is $0.00, unchanged on December 31, 2023.
- During the last 3 years, MRKR annual total debt has fallen by -$12.26 million (-100.00%).
- MRKR annual total debt is now -100.00% below its all-time high of $12.26 million, reached on December 31, 2020.
Performance
MRKR Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 26, 2025, MRKR quarterly total debt is $0.00, unchanged on September 30, 2024.
- Over the past year, MRKR quarterly total debt has stayed the same.
- MRKR quarterly total debt is now -100.00% below its all-time high of $12.26 million, reached on December 31, 2020.
Performance
MRKR Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
MRKR Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | -100.0% | 0.0% |
| 5 y5 years | 0.0% | -100.0% |
MRKR Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Marker Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $7.49 M(>+9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2022 | - | $7.72 M(-33.2%) |
| Jun 2022 | - | $11.56 M(-1.4%) |
| Mar 2022 | - | $11.72 M(-1.3%) |
| Dec 2021 | $11.87 M(-3.2%) | $11.87 M(-1.2%) |
| Sep 2021 | - | $12.01 M(-0.9%) |
| Jun 2021 | - | $12.13 M(-0.5%) |
| Mar 2021 | - | $12.19 M(-0.5%) |
| Dec 2020 | $12.26 M(+2430.9%) | $12.26 M(+0.2%) |
| Sep 2020 | - | $12.23 M(+29.0%) |
| Jun 2020 | - | $9.48 M(+2078.6%) |
| Mar 2020 | - | $435.20 K(-10.1%) |
| Dec 2019 | $484.30 K(>+9900.0%) | $484.30 K(-9.1%) |
| Sep 2019 | - | $532.80 K(-8.1%) |
| Jun 2019 | - | $579.70 K(-7.2%) |
| Mar 2019 | - | $625.00 K(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $5000.00(0.0%) |
| Jun 2018 | - | $5000.00(0.0%) |
| Mar 2018 | - | $5000.00(>+9900.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2017 | - | $5000.00(0.0%) |
| Jun 2017 | - | $5000.00(0.0%) |
| Mar 2017 | - | $5000.00(0.0%) |
| Dec 2016 | $5000.00(-90.6%) | $5000.00(0.0%) |
| Sep 2016 | - | $5000.00(-82.1%) |
| Jun 2016 | - | $28.00 K(0.0%) |
| Mar 2016 | - | $28.00 K(-47.2%) |
| Dec 2015 | $53.00 K(+0.2%) | $53.00 K(+0.2%) |
| Sep 2015 | - | $52.90 K(0.0%) |
| Jun 2015 | - | $52.90 K(0.0%) |
| Mar 2015 | - | $52.90 K(0.0%) |
| Dec 2014 | $52.90 K(-98.5%) | $52.90 K(0.0%) |
| Sep 2014 | - | $52.90 K(-88.1%) |
| Jun 2014 | - | $442.90 K(-14.9%) |
| Mar 2014 | - | $520.50 K(-85.1%) |
| Dec 2013 | $3.48 M(+124.0%) | $3.48 M(+32.1%) |
| Sep 2013 | - | $2.64 M(+3.9%) |
| Jun 2013 | - | $2.54 M(+24.3%) |
| Mar 2013 | - | $2.04 M(+31.4%) |
| Dec 2012 | $1.55 M | $1.55 M(+12.6%) |
| Sep 2012 | - | $1.38 M(+8.2%) |
| Jun 2012 | - | $1.28 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $1.16 M(+4.5%) |
| Dec 2011 | $1.11 M(+42.1%) | $1.11 M(+63.8%) |
| Sep 2011 | - | $675.10 K(+10.4%) |
| Jun 2011 | - | $611.50 K(+22.3%) |
| Mar 2011 | - | $499.80 K(-35.8%) |
| Dec 2010 | $778.10 K(+130.2%) | $778.10 K(+109.9%) |
| Sep 2010 | - | $370.70 K(+164.8%) |
| Jun 2010 | - | $140.00 K(-71.1%) |
| Mar 2010 | - | $485.00 K(+43.5%) |
| Dec 2009 | $338.00 K(-58.8%) | $338.00 K(+94.3%) |
| Sep 2009 | - | $174.00 K(+58.3%) |
| Jun 2009 | - | $109.90 K(-89.5%) |
| Mar 2009 | - | $1.05 M(+27.5%) |
| Dec 2008 | $820.00 K(+65.1%) | $820.00 K(+91.4%) |
| Sep 2008 | - | $428.50 K(-62.7%) |
| Jun 2008 | - | $1.15 M(+22.9%) |
| Mar 2008 | - | $934.40 K(+88.2%) |
| Dec 2007 | $496.60 K(-76.5%) | $496.60 K(+26.8%) |
| Sep 2007 | - | $391.60 K(+291.6%) |
| Jun 2007 | - | $100.00 K(-41.2%) |
| Mar 2007 | - | $170.00 K(-92.0%) |
| Dec 2006 | $2.11 M(+338.0%) | $2.11 M(+221.9%) |
| Sep 2006 | - | $656.80 K(-42.6%) |
| Jun 2006 | - | $1.14 M(+51.0%) |
| Mar 2006 | - | $758.10 K(+57.1%) |
| Dec 2005 | $482.70 K(+1.2%) | $482.70 K(+2.8%) |
| Sep 2005 | - | $469.70 K(+2.8%) |
| Jun 2005 | - | $456.70 K(+2.9%) |
| Mar 2005 | - | $443.70 K(-7.0%) |
| Dec 2004 | $477.10 K(>+9900.0%) | $477.10 K(+2.7%) |
| Sep 2004 | - | $464.60 K(+2.8%) |
| Jun 2004 | - | $452.10 K(>+9900.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2002 | - | $0.00(0.0%) |
| Jun 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(-100.0%) |
| Dec 2001 | $190.00 K(-2.5%) | $190.00 K(>+9900.0%) |
| Sep 2001 | - | $0.00(0.0%) |
| Jun 2001 | - | $0.00(-100.0%) |
| Mar 2001 | - | $49.70 K(-74.5%) |
| Dec 2000 | $194.80 K(+27.1%) | $194.80 K(+48.9%) |
| Sep 2000 | - | $130.80 K(-14.7%) |
| Jun 2000 | - | $153.30 K(-6.5%) |
| Mar 2000 | - | $163.90 K |
| Dec 1999 | $153.30 K | - |
FAQ
- What is Marker Therapeutics annual total debt?
- What is the all time high annual total debt for Marker Therapeutics?
- What is Marker Therapeutics annual total debt year-on-year change?
- What is Marker Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Marker Therapeutics?
- What is Marker Therapeutics quarterly total debt year-on-year change?
What is Marker Therapeutics annual total debt?
The current annual total debt of MRKR is $0.00
What is the all time high annual total debt for Marker Therapeutics?
Marker Therapeutics all-time high annual total debt is $12.26 M
What is Marker Therapeutics annual total debt year-on-year change?
Over the past year, MRKR annual total debt has changed by $0.00 (0.00%)
What is Marker Therapeutics quarterly total debt?
The current quarterly total debt of MRKR is $0.00
What is the all time high quarterly total debt for Marker Therapeutics?
Marker Therapeutics all-time high quarterly total debt is $12.26 M
What is Marker Therapeutics quarterly total debt year-on-year change?
Over the past year, MRKR quarterly total debt has changed by $0.00 (0.00%)